Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats

Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat

(2011) Rostislav Večeřa et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats

(2011) Priscila G Fassini et al.   Lipids in Health and Disease

Rhabdomyolysis Induced by Rosuvastatin and Sildenafil

(2011) Giovanni Pennisi et al.   SOUTHERN MEDICAL JOURNAL

Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats

(2011) Javed A. Ansari et al.   TOXICOLOGY MECHANISMS AND METHODS

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

(2010) Michael S. Kostapanos et al.   American Journal of Cardiovascular Drugs

New Insights into the Structural Features and Functional Relevance of Human Cytochrome P450 2C9. Part I

(2010) Sui-Lin Mo et al.   CURRENT DRUG METABOLISM

Nutritional Status Affects Fluvastatin-Induced Hepatotoxicity and Myopathy in Rats

(2010) J. Sugatani et al.   DRUG METABOLISM AND DISPOSITION

Effect of the HMG-CoA Reductase Inhibitor Rosuvastatin on Early Chronic Kidney Injury in Obese Zucker Rats Fed With an Atherogenic Diet

(2009) Efrain Reisin et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Evaluation of the binding orientations of testosterone in the active site of homology models for CYP2C11 and CYP2C13

(2009) Hongwu Wang et al.   BIOCHEMICAL PHARMACOLOGY

Differences in hepatic expression of genes involved in lipid homeostasis between hereditary hypertriglyceridemic rats and healthy Wistar rats and in their response to dietary cholesterol

(2009) J. Orolin et al.   FOOD AND CHEMICAL TOXICOLOGY